-
IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here. The OTHER forum is HERE so please stop asking.
Its Official: 0 Deaths After Israel Vaccinates 520,000. 93% Effective. End of Pandemic is near......
- Thread starter shockshiok
- Start date
520K jabs on 544 test positive means the effectiveness is 99.99% why it says 93%?
the 93% figure comes from comparing it to the non vaccinated group.
looks promising
nooooooooooo, this cant be....dont anyhow say and dash the hope of looney tune @tobelightlight, the vaxin kill rate is supposed to be more effective than the virus and will wipeout mankind, we will all becum extinct like dinosaurs
If you know the whereabouts of this person, kindly inform us so we can send our mobile unit for immediate evaluation
We can be reached at:
https://www.imh.com.sg/
Institute of Mental Health
http://www.imh.com.sg/
Buangkok Green Medical Park
10 Buangkok View
Singapore 539747
A very significant number of the Jews, who are observant, are Kosher.
Supposedly, that also apply to Muslims.
When someone dies of something else it is coded as a Covid death.
When someone dies after a Covid vaccination it is classified as unrelated to the vaccine.
https://www.jpost.com/health-scienc...ccine-reduces-risk-of-serious-covid-19-658959
94% drop in symptomatic COVID cases among Israel's vaccinated - study
Data showed 94% fewer symptomatic coronavirus cases and 92% fewer cases of serious illness among those vaccinated.
By MAAYAN JAFFE-HOFFMAN
FEBRUARY 14, 2021 20:45
People get vaccinated at the Clalit vaccination center in Jerusalem, January 3, 2020.
(photo credit: MARC ISRAEL SELLEM/THE JERUSALEM POST)
Advertisement
The Pfizer vaccine not only prevents infection but also reduces the risk of contracting a serious case of COVID-19, new data released Sunday by Clalit Health Services shows.
The data, which was based on a study of 1,200,000 people – 600,000 who received the vaccine and 600,000 who did not – showed 94% fewer symptomatic coronavirus cases and 92% fewer cases of serious illness among those who were vaccinated.
Read More Related Articles
- COVID-19: These are the cities that will reopen kindergartens and schools
- Coronavirus: Where are Israel’s Moderna vaccines?
Recommended by
The study showed that the vaccine was equally as effective among people 70 and older as it was among younger participants. Among those who were vaccinated, some 170,000 people were over the age of 60.
It was also found that the Pfizer vaccine is most effective one week after the second dose, mirroring the company’s own clinical studies.
In a preliminary examination of the results, after 14 days or more had passed since people received their second dose, the vaccines were found to have even higher efficacy for the prevention of symptomatic and severe disease, said Prof. Ran Balicer, Clalit's chief of innovation.
The control group was carefully adjusted to ensure that it paralleled those who were vaccinated, including based on level of risk for developing a serious infection, health status, age and more, according to Clalit.
Events such as quarantine and changing vaccination guidelines were also accounted for.
Latest articles from Jpost
Top Articles
SKIP AD
These results are the first in what is expected to be a series of studies released by the Clalit Research Institute to evaluate the effectiveness of the vaccine on various and diverse groups, Balicer said.
“For weeks, we have developed tools and methodologies to deal with the many biases that characterize this type of research in real-world data,” he said, adding that Clalit worked with colleagues at Harvard University to perform a series of tests to validate the results.
Last week, Maccabi Healthcare Services shared preliminary data on its own vaccination campaign, highlighting that fewer than 0.1% of individuals who received their second dose of the Pfizer vaccine contracted COVID-19.
Maccabi showed vaccine effectiveness in Israel to be at 93%. Pfizer’s Phase III clinical trial showed it to be 95% effective.
Clalit said it has given out more than 3.2 million first and second vaccine doses.
In total, Israel has administered more than 6.3 million vaccine doses.
94 even betterhttps://www.jpost.com/health-scienc...ccine-reduces-risk-of-serious-covid-19-658959
94% drop in symptomatic COVID cases among Israel's vaccinated - study
Data showed 94% fewer symptomatic coronavirus cases and 92% fewer cases of serious illness among those vaccinated.
By MAAYAN JAFFE-HOFFMAN
FEBRUARY 14, 2021 20:45
People get vaccinated at the Clalit vaccination center in Jerusalem, January 3, 2020.
(photo credit: MARC ISRAEL SELLEM/THE JERUSALEM POST)
Advertisement
The Pfizer vaccine not only prevents infection but also reduces the risk of contracting a serious case of COVID-19, new data released Sunday by Clalit Health Services shows.
The data, which was based on a study of 1,200,000 people – 600,000 who received the vaccine and 600,000 who did not – showed 94% fewer symptomatic coronavirus cases and 92% fewer cases of serious illness among those who were vaccinated.
Read More Related Articles
- COVID-19: These are the cities that will reopen kindergartens and schools
- Coronavirus: Where are Israel’s Moderna vaccines?
Recommended by
The study showed that the vaccine was equally as effective among people 70 and older as it was among younger participants. Among those who were vaccinated, some 170,000 people were over the age of 60.
It was also found that the Pfizer vaccine is most effective one week after the second dose, mirroring the company’s own clinical studies.
In a preliminary examination of the results, after 14 days or more had passed since people received their second dose, the vaccines were found to have even higher efficacy for the prevention of symptomatic and severe disease, said Prof. Ran Balicer, Clalit's chief of innovation.
The control group was carefully adjusted to ensure that it paralleled those who were vaccinated, including based on level of risk for developing a serious infection, health status, age and more, according to Clalit.
Events such as quarantine and changing vaccination guidelines were also accounted for.
Latest articles from Jpost
Top ArticlesREAD MOREIn message to Hezbollah, IAF practices striking 3,000targets in 24 hours
SKIP AD
These results are the first in what is expected to be a series of studies released by the Clalit Research Institute to evaluate the effectiveness of the vaccine on various and diverse groups, Balicer said.
“For weeks, we have developed tools and methodologies to deal with the many biases that characterize this type of research in real-world data,” he said, adding that Clalit worked with colleagues at Harvard University to perform a series of tests to validate the results.
Last week, Maccabi Healthcare Services shared preliminary data on its own vaccination campaign, highlighting that fewer than 0.1% of individuals who received their second dose of the Pfizer vaccine contracted COVID-19.
Maccabi showed vaccine effectiveness in Israel to be at 93%. Pfizer’s Phase III clinical trial showed it to be 95% effective.
Clalit said it has given out more than 3.2 million first and second vaccine doses.
In total, Israel has administered more than 6.3 million vaccine doses.
https://www.jpost.com/health-scienc...ccine-reduces-risk-of-serious-covid-19-658959
94% drop in symptomatic COVID cases among Israel's vaccinated - study
Data showed 94% fewer symptomatic coronavirus cases and 92% fewer cases of serious illness among those vaccinated.
By MAAYAN JAFFE-HOFFMAN
FEBRUARY 14, 2021 20:45
People get vaccinated at the Clalit vaccination center in Jerusalem, January 3, 2020.
(photo credit: MARC ISRAEL SELLEM/THE JERUSALEM POST)
Advertisement
The Pfizer vaccine not only prevents infection but also reduces the risk of contracting a serious case of COVID-19, new data released Sunday by Clalit Health Services shows.
The data, which was based on a study of 1,200,000 people – 600,000 who received the vaccine and 600,000 who did not – showed 94% fewer symptomatic coronavirus cases and 92% fewer cases of serious illness among those who were vaccinated.
Read More Related Articles
- COVID-19: These are the cities that will reopen kindergartens and schools
- Coronavirus: Where are Israel’s Moderna vaccines?
Recommended by
The study showed that the vaccine was equally as effective among people 70 and older as it was among younger participants. Among those who were vaccinated, some 170,000 people were over the age of 60.
It was also found that the Pfizer vaccine is most effective one week after the second dose, mirroring the company’s own clinical studies.
In a preliminary examination of the results, after 14 days or more had passed since people received their second dose, the vaccines were found to have even higher efficacy for the prevention of symptomatic and severe disease, said Prof. Ran Balicer, Clalit's chief of innovation.
The control group was carefully adjusted to ensure that it paralleled those who were vaccinated, including based on level of risk for developing a serious infection, health status, age and more, according to Clalit.
Events such as quarantine and changing vaccination guidelines were also accounted for.
Latest articles from Jpost
Top ArticlesREAD MOREIn message to Hezbollah, IAF practices striking 3,000targets in 24 hours
SKIP AD
These results are the first in what is expected to be a series of studies released by the Clalit Research Institute to evaluate the effectiveness of the vaccine on various and diverse groups, Balicer said.
“For weeks, we have developed tools and methodologies to deal with the many biases that characterize this type of research in real-world data,” he said, adding that Clalit worked with colleagues at Harvard University to perform a series of tests to validate the results.
Last week, Maccabi Healthcare Services shared preliminary data on its own vaccination campaign, highlighting that fewer than 0.1% of individuals who received their second dose of the Pfizer vaccine contracted COVID-19.
Maccabi showed vaccine effectiveness in Israel to be at 93%. Pfizer’s Phase III clinical trial showed it to be 95% effective.
Clalit said it has given out more than 3.2 million first and second vaccine doses.
In total, Israel has administered more than 6.3 million vaccine doses.
the important thing is this is the 1st major non clinical trial real world data so far. Israel has vaccinated 30% of its population, the UK is coming closer to this mark and the United States should be next 2 months.
But its assured, the vaccine works, these are real numbers
0 deaths is the real number here
the important thing is this is the 1st major non clinical trial real world data so far. Israel has vaccinated 30% of its population, the UK is coming closer to this mark and the United States should be next 2 months.
But its assured, the vaccine works, these are real numbers
0 deaths is the real number here
also fun forget to wear mask. mask very good for stop the covid transmission
Ang moh vaccine only for minister
If they say yes I'll pay 5K today
We already have Pfizer here in Singapore, Moderna will be here next month. No one wants to wait, but no choice.
We already have Pfizer here in Singapore, Moderna will be here next month. No one wants to wait, but no choice.
more ang moh vaccines better
Faster patience running out
the important thing is this is the 1st major non clinical trial real world data so far. Israel has vaccinated 30% of its population, the UK is coming closer to this mark and the United States should be next 2 months.
But its assured, the vaccine works, these are real numbers
0 deaths is the real number here
tiong death is 10,000, jew death is 0.
first time i say go with the jew
Jews are the privilege human race ever to live. The Arab are lazy and stupid. No wonder they can't make it. Look at the 7 days war, they can't even run the tiny ABRAHAM Descendents down.
Similar threads
